Financial Statements · Financial Reporting
TRIZLEX BIOPHARMA OÜ
Official identifier 11220756Record date 31 Dec 2020
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2020
- Period start
- 1 Jan 2020
- Submitted date
- 9 Oct 2021
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 182,399 |
| Balance sheet | Cash and cash equivalents | 112,157 |
| Balance sheet | Current assets | 182,399 |
| Balance sheet | Current liabilities | 2,542 |
| Balance sheet | Equity | 119,857 |
| Balance sheet | Share capital at nominal value | 2,556 |
| Balance sheet | Non-current assets | 0 |
| Balance sheet | Non-current liabilities | 60,000 |
| Balance sheet | Retained earnings (loss) from previous periods | 66,697 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | 0 |
| Income statement scheme 1 | Labour costs | -2,286 |
| Income statement scheme 1 | Revenue | 245,004 |
| Income statement scheme 1 | Annual period profit / loss | 50,604 |
| Income statement scheme 1 | Operating profit (loss) | 50,604 |
| Income statement scheme 1 | Profit (loss) before income tax | 50,604 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 66,697 |
| Note: Labour costs | Employees | 1 |
| Note: Labour costs | Labour costs | 2,285 |
Linked company
Company: TRIZLEX BIOPHARMA OÜ